Skip to content

Study to evaluate whether VAJ Yoga improves mental health in people with depression.

Effects of VAJ Yoga on Mental Health via Psychological, Electrophysiological, and Biochemical Indices in Patients having Depression - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106899
Enrollment
612
Registered
2026-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

Intervention1: VAJ Yoga Program: articipants in the intervention arm will receive a structured VAJ Yoga program in addition to standard medical treatment for depression. The VAJ Yoga program will cons

Sponsors

Pacific Medical College & Hospital, Pacific Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female participants aged 18 to 80 years diagnosed with major depressive disorder with Hamilton Depression Rating Scale score greater than or equal to 20 receiving standard treatment and willing to participate in VAJ Yoga intervention for 12 weeks and able to provide written informed consent with no regular yoga practice in the last 6 months.

Exclusion criteria

Exclusion criteria: Patients with severe psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder, psychosis). Patients with serious uncontrolled medical illnesses (e.g., severe cardiovascular disease, renal failure, liver disease, or malignancy). Patients with neurological disorders affecting participation or EEG interpretation. Patients with substance or alcohol dependence. Patients who have regularly practiced yoga or meditation within the last 6 months. Patients unable to participate in yoga sessions due to physical disability or severe illness. Patients unwilling or unable to provide written informed consent. Participants unlikely to complete the 12-week follow-up period.

Design outcomes

Primary

MeasureTime frame
Change in DASS-42 total score (Depression + Anxiety + Stress subscales) from baselineTimepoint: Change in DASS-42 total score (Depression + Anxiety + Stress subscales) from baseline

Secondary

MeasureTime frame
Change in HAM-D (Hamilton Depression Rating Scale) score from baselineTimepoint: Baseline (Week 0) and Week 12;Change in Oxford Happiness Questionnaire (OHQ) scoreTimepoint: Baseline (Week 0) and Week 12;Change in Emotional Quotient (EQ) score (NHS scale)Timepoint: Baseline (Week 0) and Week 12;Change in Spiritual Quotient (SQ) score (SISRI-24)Timepoint: Baseline (Week 0) and Week 12;Change in cognitive performance (WAIS-IV Digit Span / Working Memory index)Timepoint: Baseline (Week 0) and Week 12;Change in quantitative EEG band power (alpha, beta, theta, delta) in frontal, parietal and temporal regionsTimepoint: Baseline (Week 0) and Week 12;Change in serum serotonin concentrationTimepoint: Baseline (Week 0) and Week 12;Change in serum dopamine concentrationTimepoint: Baseline (Week 0) and Week 12

Countries

India

Contacts

Public ContactJeshurun Mathew James

Pacific Medical College and Hospital, Pacific Medical University

ametatushar20@gmail.com8094849002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026